HUMAN IMMUNODEFICIENCY VIRUS
Clinical trials for HUMAN IMMUNODEFICIENCY VIRUS explained in plain language.
Never miss a new study
Get alerted when new HUMAN IMMUNODEFICIENCY VIRUS trials appear
Sign up with your email to follow new studies for HUMAN IMMUNODEFICIENCY VIRUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
HIV pill combo fails to slim belly fat in early trial
Disease control TerminatedThis study tested whether switching to a two-drug HIV treatment (raltegravir plus maraviroc) could reduce belly fat (lipohypertrophy) in people whose HIV was already well-controlled. It included 48 adults on stable HIV therapy for at least 5 years. The study was stopped early, so…
Matched conditions: HUMAN IMMUNODEFICIENCY VIRUS
Phase: PHASE2 • Sponsor: ANRS, Emerging Infectious Diseases • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New program aims to boost HIV medication adherence for medicaid patients
Disease control TerminatedThis study tested a program to help Virginia Medicaid enrollees with HIV fill their antiretroviral prescriptions on time. The program offered support from providers, pharmacies, and community groups, with extra help for those who were very late refilling. Only 4 people enrolled b…
Matched conditions: HUMAN IMMUNODEFICIENCY VIRUS
Phase: NA • Sponsor: Virginia Commonwealth University • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
HIV Antibody-Only therapy falls short in Long-Term trial
Disease control TerminatedThis study tested whether a single antibody called PRO 140 could keep HIV under control in 20 adults who had been stable on standard combination therapy. Participants stopped their usual HIV pills and received only PRO 140 infusions. The trial was stopped early, and the main goal…
Matched conditions: HUMAN IMMUNODEFICIENCY VIRUS
Phase: PHASE2 • Sponsor: CytoDyn, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC